Suffolk Capital Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$304K Sell
14,879
-6,060
-29% -$190K 0.06% 105
2018
Q3
$772K Buy
20,939
+4,402
+27% +$192K 0.11% 99
2018
Q2
$831K Sell
16,537
-7,070
-30% -$312K 0.12% 84
2018
Q1
$862K Sell
23,607
-7,444
-24% -$228K 0.12% 78
2017
Q4
$879K Sell
31,051
-46,136
-60% -$1.09M 0.11% 84
2017
Q3
$1.49M Sell
77,187
-11,675
-13% -$196K 0.2% 60
2017
Q2
$1.49M Sell
88,862
-56,155
-39% -$757K 0.2% 95
2017
Q1
$1.51M Sell
145,017
-30,067
-17% -$307K 0.2% 76
2016
Q4
$1.58M Buy
+175,084
New +$1.51M 0.22% 79

Other funds holding AXGN

Suffolk Capital Management's AXGN Position: Q4 2018 in Review

Suffolk Capital Management reduced its Axogen (AXGN) stake by 29% in Q4 2018, selling an estimated $190K and leaving 14,879 shares worth $304K. The position accounts for 0.06% of the portfolio, ranked #105.

Suffolk Capital Management first reported a position in AXGN in Q4 2016 and has held it in 9 quarters since. The position peaked at $1.58M in Q4 2016. 146 funds tracked by Wall St. Rank hold AXGN as of Q4 2018.

  • Suffolk Capital Management held 14,879 shares of Axogen worth $304K as of Q4 2018.
  • Suffolk Capital Management sold 6,060 Axogen shares in Q4 2018, an estimated $190K.
  • Axogen made up 0.06% of Suffolk Capital Management's portfolio in Q4 2018, its #105 holding.
  • Suffolk Capital Management first reported a position in Axogen in Q4 2016 and has held it in 9 quarters since.
  • Suffolk Capital Management's Axogen position peaked at $1.58M in Q4 2016.
  • 146 funds tracked by Wall St. Rank held Axogen as of Q4 2018.

Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.